Suppr超能文献

腹腔镜辅助 D2 淋巴结清扫术治疗无浆膜侵犯的进展期胃癌:来自华南地区的一项匹配队列研究。

Laparoscopy-assisted gastrectomy with D2 lymph node dissection for advanced gastric cancer without serosa invasion: a matched cohort study from South China.

机构信息

Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, Fujian Province, China.

出版信息

World J Surg Oncol. 2013 Jan 11;11:4. doi: 10.1186/1477-7819-11-4.

Abstract

BACKGROUND

Gastric cancer is a common malignancy worldwide and a common cause of death from cancer. Despite recent advances in multimodality treatment and targeted therapy, complete resection remains the only treatment that can lead to cure. This study was devised to investigate the technical feasibility, safety and oncologic efficacy of laparoscopy-assisted gastrectomy for advanced gastric cancer without serosa invasion.

METHODS

A retrospective matched cohort study was performed in south China comparing laparoscopy-assisted gastrectomy and open gastrectomy for advanced gastric cancer without serosa invasion. Eighty-three patients with advanced gastric cancer undergoing laparoscopy-assisted gastrectomy between January 2008 and December 2010 were enrolled. These patients were compared with 83 patients with advanced gastric cancer undergoing open gastrectomy during the same period.

RESULTS

There was no significant difference in clinicopathologic characteristics between the two groups. Regarding perioperative characteristics, the operation time and time to ground activities did not differ between the two groups, whereas the blood loss, transfused patient number, time to first flatus, time to resumption of diet, and postoperative hospital stay were significantly less in laparoscopy-assisted gastrectomy than in open gastrectomy (P <0.05). There was no statistically significant difference in postoperative morbidity and mortality. No significant difference in the number of lymph nodes dissected was observed between these two groups. There was no significant difference in the cumulative survival rate between the two groups.

CONCLUSION

Laparoscopy-assisted gastrectomy with D2 lymphadenectomy is a safe and feasible procedure for advanced gastric cancer without serosa invasion. To be accepted as a choice treatment for advanced gastric cancer, well-designed randomized controlled trials comparing short-term and long-term outcomes between laparoscopy-assisted gastrectomy and open gastrectomy in a larger number of patients are necessary.

摘要

背景

胃癌是全球常见的恶性肿瘤之一,也是癌症死亡的常见原因。尽管多模式治疗和靶向治疗最近取得了进展,但完全切除仍然是唯一可以治愈的治疗方法。本研究旨在探讨腹腔镜辅助胃切除术治疗无浆膜侵犯的进展期胃癌的技术可行性、安全性和肿瘤学疗效。

方法

在中国南方进行了一项回顾性匹配队列研究,比较了腹腔镜辅助胃切除术和开放性胃切除术治疗无浆膜侵犯的进展期胃癌。纳入 2008 年 1 月至 2010 年 12 月期间接受腹腔镜辅助胃切除术治疗的 83 例进展期胃癌患者。这些患者与同期接受开放性胃切除术治疗的 83 例进展期胃癌患者进行了比较。

结果

两组患者的临床病理特征无显著差异。关于围手术期特征,两组的手术时间和下地活动时间无差异,但腹腔镜辅助胃切除术组的出血量、输血患者数、首次排气时间、恢复饮食时间和术后住院时间均显著少于开放性胃切除术组(P<0.05)。两组术后发病率和死亡率无统计学差异。两组淋巴结清扫数目无显著差异。两组累积生存率无显著差异。

结论

对于无浆膜侵犯的进展期胃癌,腹腔镜辅助 D2 淋巴结清扫术是一种安全可行的手术方法。为了被接受为进展期胃癌的治疗选择,需要设计良好的随机对照试验,在更多患者中比较腹腔镜辅助胃切除术和开放性胃切除术的短期和长期结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa08/3566945/6d0c2fc4c1a7/1477-7819-11-4-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验